Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1989-10-13
pubmed:abstractText
TGF-alpha-PE40 is a hybrid protein composed of transforming growth factor-alpha (TGF-alpha) fused to a 40,000-dalton segment of Pseudomonas exotoxin A (PE40). This hybrid protein possesses the receptor-binding activity of TGF-alpha and the cell-killing properties of PE40. These properties enable TGF-alpha-PE40 to bind to and kill tumor cells that possess epidermal growth factor (EGF) receptors. Unexpectedly, TGF-alpha-PE40 binds approximately 100-fold less effectively to EGF receptors than does native TGF-alpha (receptor-binding inhibition IC50 = 540 and 5.5 nM, respectively). To understand the factors governing receptor binding, deletions and site-specific substitutions were introduced into the PE40 domain of TGF-alpha-PE40. Removal of the N-terminal 59 or 130 amino acids from the PE40 domain of TGF-alpha-PE40 improved receptor binding (IC50 = 340 and 180 nM, respectively) but decreased cell-killing activity. Substitution of alanines for cysteines at positions 265 and 287 within the PE40 domain dramatically improved receptor binding (IC50 = 37 nM) but also decreased cell-killing activity. Similar substitutions of alanines for cysteines at positions 372 and 379 within the PE40 domain did not significantly affect receptor-binding or cell-killing activities. These studies indicate that the PE40 domain of TGF-alpha-PE40 interferes with EGF receptor binding. The cysteine residues at positions 265 and 287 of PE40 are responsible for a major part of this interference.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-1105573, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-166383, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-19354, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-265521, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-2710128, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-2850475, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-2981413, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-2999006, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3006045, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3095831, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3098436, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3131768, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3132465, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3283735, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3299371, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3477813, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3501577, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3531211, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-3855503, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-4357758, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6201861, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6269464, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6276390, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6312838, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6320373, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6606682, http://linkedlifedata.com/resource/pubmed/commentcorrection/2779550-6811955
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ADP Ribose Transferases, http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Toxins, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Exotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors, http://linkedlifedata.com/resource/pubmed/chemical/toxA protein, Pseudomonas aeruginosa
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0270-7306
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2860-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor-alpha-Pseudomonas exotoxin fusion proteins.
pubmed:affiliation
Department of Cancer Research, Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
pubmed:publicationType
Journal Article